RA'SHUN CONNER: Open Payments
NPI 1245983386 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $116 |
| ABBVIE INC. | 1 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Novo Nordisk Inc | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: FARXIGA, QULIPTA, MOUNJARO, NEXLETOL, AIRSUPRA, CAPLYTA.
Industry payments across AL — which companies pay providers there.
